Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

New Line of PCR Workstations Provide Contamination-Free Zones on the Bench

By BiotechDaily International staff writers
Posted on 26 Aug 2013
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
A timely new product for biotech laboratories provides molecular biology investigators with a “personal cleanroom” for use while performing PCR preparations prior to the amplification of DNA and RNA.

Products in the new line of MY‑PCR Prep Stations manufactured by Mystaire Misonix (Creedmoor, NC, USA) establish bench-top personal clean zones that enable the investigator to amplify RNA and DNA while minimizing the potential for background from airborne contaminants.

The workstations, which are available in 61 cm and 81 cm-wide models, are the equivalent of Class 100 vertical laminar flow hoods with timed UV light.

Airborne contaminants are prevented from entering into the work zone through constant positive pressure HEPA filtered air. Each MY-PCR Prep Station is equipped with a built-in 254 nanometer shortwave lamp to effectively decontaminate the work area between amplifications. Safety interlocks are included on all PCR Prep Stations to prevent operator exposure to potentially harmful UV radiation.

The main chamber of MY-PCR Prep is constructed from a continuous piece of polycarbonate to prevent UV light from escaping the chamber during irradiation. Operator access is gained through the folding front polycarbonate sash, overlapped to eliminate gaps in the chamber during operation of the UV light. The work surface is white polypropylene that facilitates cleaning and disinfection.

The manufacturer reminds MY-PCR operators that the workstations are not biological safety cabinets. They are designed to provide process protection only from potential airborne contaminants found in the laboratory space.

Related Links:
Mystaire Misonix




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.